Skip to main content
NVDA+0.50%AAPL-1.06%GOOGL-1.68%MSFT-1.23%AMZN-1.85%TSM-0.93%SPCX-1.99%META+0.28%AVGO-1.16%TSLA+0.27%SKHY-0.31%BRK-B+0.13%LLY+0.73%MU+0.56%JPM-1.42%WMT-0.33%AMD+2.15%V-0.29%XOM+2.59%JNJ-0.66%ASMLa-1.24%0700.HK+1.90%MA-0.47%INTC+1.61%ABBV+0.66%1398.HK-2.09%CSCO+0.70%CVX+2.05%BAC-0.63%ORCL-0.58%COST-1.13%KO-0.84%DELL+3.55%CAT-0.33%HSBA.L-2.32%0005.HK-3.21%PG+0.64%UNH-1.71%LRCX-2.19%AP2d-2.41%AMAT-1.12%1816.HK-0.46%3988.HK-2.13%NFLX-3.04%GE-3.04%MS-2.37%0857.HK+0.60%HD-1.57%PM+0.12%0939.HK-2.83%USDJPY+1.01%NZDUSD-0.97%CHFJPY+0.77%USDTHB+0.73%CADJPY+0.68%GBPJPY+0.67%GBPNZD+0.66%NZDCHF-0.64%NZDCAD-0.64%AUDUSD-0.59%EURJPY+0.50%EURNZD+0.49%EURUSD-0.48%AUDJPY+0.44%PLNJPY+0.42%GBPTRY+0.41%NOKJPY+0.41%AUDNZD+0.39%USDCAD+0.34%USDCHF+0.33%GBPHKD+0.32%GBPUSD-0.31%SGDJPY+0.31%NZDMXN-0.30%GBPMXN-0.28%GBPAUD+0.25%AUDCHF-0.25%USDTRY+0.25%AUDCAD-0.24%USDSEK+0.22%USDSGD+0.20%EURCAD-0.17%NZDSGD-0.17%EURSEK+0.16%USDILS+0.16%GBPZAR-0.15%EURSGD+0.14%EURGBP-0.14%EURCHF-0.14%EURCZK+0.12%EURAUD+0.12%CHFNOK-0.12%USDNOK+0.10%AUDDKK-0.10%USDPLN+0.08%USDCNH+0.07%USDMXN+0.07%EURZAR-0.07%GBPSGD+0.06%AUDNOK-0.06%NZDJPY+0.05%USDDKK+0.05%AUDSGD+0.04%EURHKD-0.04%EURNOK+0.04%USDCOP-0.04%EURPLN+0.03%CHFSGD-0.02%CADCHF-0.02%USDHKD+0.02%GBPCAD+0.02%USDZAR-0.01%GBPCHF-0.01%EURDKK-0.01%EURCNH-0.01%CHFSEK0.00%USOIL+2.64%W1+1.93%COCOA-1.67%UKOIL+1.63%COFFEE-1.37%SUGAR-1.27%XNGUSD+1.17%C1+1.14%S1+1.11%HG1+0.47%XAUUSD-0.33%GAUUSD-0.33%BTCUSD-2.39%ETHUSD-3.55%USDTUSD-0.04%XRPUSD-2.10%SOLUSD-3.13%TRXUSDT-0.47%ZECUSDT-3.20%DOGEUSD-2.16%XMRUSDT+0.58%LINKUSD-2.09%XLMUSD+0.90%BCHUSDT-1.16%UNIUSD-2.78%LTCUSD-2.54%HBARUSDT+0.08%TONUSD+26.79%SUIUSD-2.38%TAOUSDT-2.73%AAVEUSD-1.97%DOTUSDT-1.81%ICPUSDT-6.85%ONDOUSDT-2.95%WLDUSDT-1.03%ARBUSDT+7.79%ATOMUSDT-1.16%JUPUSDT-4.72%INJUSDT-9.22%STXUSDT-2.73%FETUSDT-3.95%PYTHUSDT-3.93%TIAUSDT-5.86%SEIUSDT-2.47%IMXUSDT-1.81%OPUSDT-0.72%GRTUSDT-3.61%POLUSDT+0.48%WIFUSDT-4.27%IOTAUSDT-5.53%AXSUSDT-2.84%FARTCOINUSDT-1.32%EOSUSDT-4.33%DYDXUSDT-5.81%ORDIUSDT-1.57%GALAUSDT-0.88%NOTUSDT-2.37%RONINUSDT-14.59%NVDA+0.50%AAPL-1.06%GOOGL-1.68%MSFT-1.23%AMZN-1.85%TSM-0.93%SPCX-1.99%META+0.28%AVGO-1.16%TSLA+0.27%SKHY-0.31%BRK-B+0.13%LLY+0.73%MU+0.56%JPM-1.42%WMT-0.33%AMD+2.15%V-0.29%XOM+2.59%JNJ-0.66%ASMLa-1.24%0700.HK+1.90%MA-0.47%INTC+1.61%ABBV+0.66%1398.HK-2.09%CSCO+0.70%CVX+2.05%BAC-0.63%ORCL-0.58%COST-1.13%KO-0.84%DELL+3.55%CAT-0.33%HSBA.L-2.32%0005.HK-3.21%PG+0.64%UNH-1.71%LRCX-2.19%AP2d-2.41%AMAT-1.12%1816.HK-0.46%3988.HK-2.13%NFLX-3.04%GE-3.04%MS-2.37%0857.HK+0.60%HD-1.57%PM+0.12%0939.HK-2.83%USDJPY+1.01%NZDUSD-0.97%CHFJPY+0.77%USDTHB+0.73%CADJPY+0.68%GBPJPY+0.67%GBPNZD+0.66%NZDCHF-0.64%NZDCAD-0.64%AUDUSD-0.59%EURJPY+0.50%EURNZD+0.49%EURUSD-0.48%AUDJPY+0.44%PLNJPY+0.42%GBPTRY+0.41%NOKJPY+0.41%AUDNZD+0.39%USDCAD+0.34%USDCHF+0.33%GBPHKD+0.32%GBPUSD-0.31%SGDJPY+0.31%NZDMXN-0.30%GBPMXN-0.28%GBPAUD+0.25%AUDCHF-0.25%USDTRY+0.25%AUDCAD-0.24%USDSEK+0.22%USDSGD+0.20%EURCAD-0.17%NZDSGD-0.17%EURSEK+0.16%USDILS+0.16%GBPZAR-0.15%EURSGD+0.14%EURGBP-0.14%EURCHF-0.14%EURCZK+0.12%EURAUD+0.12%CHFNOK-0.12%USDNOK+0.10%AUDDKK-0.10%USDPLN+0.08%USDCNH+0.07%USDMXN+0.07%EURZAR-0.07%GBPSGD+0.06%AUDNOK-0.06%NZDJPY+0.05%USDDKK+0.05%AUDSGD+0.04%EURHKD-0.04%EURNOK+0.04%USDCOP-0.04%EURPLN+0.03%CHFSGD-0.02%CADCHF-0.02%USDHKD+0.02%GBPCAD+0.02%USDZAR-0.01%GBPCHF-0.01%EURDKK-0.01%EURCNH-0.01%CHFSEK0.00%USOIL+2.64%W1+1.93%COCOA-1.67%UKOIL+1.63%COFFEE-1.37%SUGAR-1.27%XNGUSD+1.17%C1+1.14%S1+1.11%HG1+0.47%XAUUSD-0.33%GAUUSD-0.33%BTCUSD-2.39%ETHUSD-3.55%USDTUSD-0.04%XRPUSD-2.10%SOLUSD-3.13%TRXUSDT-0.47%ZECUSDT-3.20%DOGEUSD-2.16%XMRUSDT+0.58%LINKUSD-2.09%XLMUSD+0.90%BCHUSDT-1.16%UNIUSD-2.78%LTCUSD-2.54%HBARUSDT+0.08%TONUSD+26.79%SUIUSD-2.38%TAOUSDT-2.73%AAVEUSD-1.97%DOTUSDT-1.81%ICPUSDT-6.85%ONDOUSDT-2.95%WLDUSDT-1.03%ARBUSDT+7.79%ATOMUSDT-1.16%JUPUSDT-4.72%INJUSDT-9.22%STXUSDT-2.73%FETUSDT-3.95%PYTHUSDT-3.93%TIAUSDT-5.86%SEIUSDT-2.47%IMXUSDT-1.81%OPUSDT-0.72%GRTUSDT-3.61%POLUSDT+0.48%WIFUSDT-4.27%IOTAUSDT-5.53%AXSUSDT-2.84%FARTCOINUSDT-1.32%EOSUSDT-4.33%DYDXUSDT-5.81%ORDIUSDT-1.57%GALAUSDT-0.88%NOTUSDT-2.37%RONINUSDT-14.59%
NE

Neurogene Inc. (NGNE)

NASDAQ • Healthcare

$35.21
-$0.26 (-0.8%)
Market open

Last close at September 14, 2026 at 20:00 UTC

Open$35.92
Previous Close$35.21
Day Range$34.7 - $36.28
Avg. Volume (3M)219.1K
Market Cap$537.1M
52 Week Range
$15.93$43.66
Next EarningsIn 58 daysNov 12, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$111.1M
EPS (TTM)
-$5.51
ROA (TTM)
-45.47%
Current Ratio
10.64

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+9.6%Q1 2026-$1.12
-7.2%Q2 2026-$1.39
-7.7%Q3 2026-$1.53
Next

Nov 12

in 58 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -7.7%

Neurogene trailed consensus on EPS in the second fiscal quarter of 2026, based on preliminary results reported August 11, 2026, with EPS of -$1.53 trailing the -$1.42 estimate by -$0.11 and down from -$1.05 a year ago (-45.7% YoY). The clinical-stage gene therapy developer posted a GAAP net loss of roughly $34.5 million, versus a net loss of about $22.0 million a year ago (-56.6% YoY), alongside an operating loss of around $36.7 million as it continued advancing its pipeline programs, including NGN-401 and NGN-101. Cash burn remained evident, with operating cash flow of about -$23.8 million for the quarter. For the next period, consensus calls for EPS of -$1.39.

View full earnings history

About Neurogene Inc.

Neurogene Inc. is a NASDAQ-listed Biotechnology company in healthcare that develops genetic medicines for neurological conditions. The company remains a clinical-stage business rather than a commercial drug seller, and its work centers on rare neurologic disorders through a focused pipeline built around gene therapy candidates.

Name
Neurogene Inc.
CEO
Rachel L. McMinn
Website
www.neurogene.com
Industry
Healthcare
Employees
131

Today's Snapshot

AI-generated

The session opened with NGNE slightly lower at 35.04, while its sector was flat.

Trading Volume

Below 10d avg (184.4K)

20.9K

vs S&P 500 Today

Underperforming Market

-2.84%

Updated: September 15, 2026 at 14:56 UTC

Technical Indicators

3 Buy1 Neutral4 Sell
NGNE displays a neutral stance with mixed signals: the price is around 34.15 and sits below several short- and medium-term averages, yet longer-term 100/200-day averages are supportive, indicating a split timeframe picture. Momentum indicators are conflicted—CCI deeply negative while stochastic and Williams %R show oversold/buying bounce—while MACD and RSI remain slightly negative to neutral. ADX around 13 points to a lack of trend conviction, ATR is elevated near 2.32, and OBV shows distribution. Technical takeaway: Neutral — opposing short-term weakness and longer-term support create a balanced technical profile.
All signals
  • EMA (5 indicators)$28.93 - $36.76
    Sell
  • RSI (14)39.75
    Neutral
  • Stochastic %K (14, 3, 3)4.06
    Buy
  • MACD Level (12, 26)-0.18
    Sell

Peers & Related Assets

ALMSAlumis Inc.
$9.22+0.4%
SLDBSolid Biosciences Inc.
$8.74+0.5%
FULCFulcrum Therapeutics, Inc.
$3.79-0.3%
QSIQuantum-Si incorporated
$0.73-2.0%
ADCTADC Therapeutics S.A.
$1.11+3.7%
PRTCPureTech Health plc
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.